Studying skin melanoma in young people to improve diagnosis

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children, teenagers and young adults under 30 with a confirmed diagnosis of melanoma or a borderline melanocytic skin growth.

Age

Younger than 20 years (children and teenagers) or younger than 30 years (young adults).

Sex

Anyone can join.

Disease stage

Melanoma, or an intermediate or ambiguous melanocytic neoplasm (melanocytoma, SAMPUS, IAMPUS or MELTUMP), confirmed by tissue examination.

Main reasons for not taking part

• Adult patients older than 30 years
• No tissue-confirmed diagnosis of melanoma or intermediate/ambiguous melanocytic neoplasm

The registry criteria, word for word

What the trial wants to find out

The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need for this study arises because this disease, in CAYA patients, is still poorly understood due to its rarity in individuals under 30 years old. This often leads to difficulties in assessing its severity and, consequently, in deciding on the necessary treatments to ensure the patient\'s recovery. The goal of this study is to examine melanoma in CAYA patients in order to gather the information needed to provide better diagnoses for affected patients and, as a result, select appropriate treatments to fight the disease and promote the patient\'s full recovery. Additionally, the data collected will be used to create a Pan-European online platform that will allow doctors across the European Union to consult the obtained data and collaborate on particularly complex melanoma cases, always with the aim of ensuring the patient\'s full recovery in the shortest possible time.

The group in the trial

• CAYA Melanoma patients

  Patients under 30 years of age at the moment of melanoma diagnosis. The patients have been divided in Children (1-14 yrs), Adolescents (15-18 yrs) and Young Adults (18-30 yrs) based on the age of diagnosis.